ZA984314B - Clear injectable formulation of an anaesthetic compound - Google Patents
Clear injectable formulation of an anaesthetic compoundInfo
- Publication number
- ZA984314B ZA984314B ZA984314A ZA984314A ZA984314B ZA 984314 B ZA984314 B ZA 984314B ZA 984314 A ZA984314 A ZA 984314A ZA 984314 A ZA984314 A ZA 984314A ZA 984314 B ZA984314 B ZA 984314B
- Authority
- ZA
- South Africa
- Prior art keywords
- injectable formulation
- anaesthetic compound
- clear
- clear injectable
- anaesthetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01224/97A CH692322A5 (it) | 1997-05-26 | 1997-05-26 | Formulazione iniettabile limpida di Propofol. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA984314B true ZA984314B (en) | 1998-12-08 |
Family
ID=4205400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA984314A ZA984314B (en) | 1997-05-26 | 1998-05-21 | Clear injectable formulation of an anaesthetic compound |
Country Status (23)
Country | Link |
---|---|
US (1) | US6326406B1 (pt) |
EP (1) | EP0991405B1 (pt) |
JP (1) | JP2001527577A (pt) |
KR (1) | KR20010013011A (pt) |
CN (1) | CN1268051A (pt) |
AR (1) | AR012853A1 (pt) |
AT (1) | ATE230984T1 (pt) |
AU (1) | AU735020B2 (pt) |
BR (1) | BR9809492A (pt) |
CA (1) | CA2291261A1 (pt) |
CH (1) | CH692322A5 (pt) |
DE (1) | DE69810771D1 (pt) |
DZ (1) | DZ2503A1 (pt) |
HU (1) | HUP0002117A3 (pt) |
IN (1) | IN187550B (pt) |
MY (1) | MY132911A (pt) |
NO (1) | NO995831L (pt) |
PA (1) | PA8451701A1 (pt) |
PE (1) | PE75299A1 (pt) |
PL (1) | PL337026A1 (pt) |
TR (1) | TR200000116T2 (pt) |
WO (1) | WO1998053805A1 (pt) |
ZA (1) | ZA984314B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
ATE283042T1 (de) * | 1999-01-28 | 2004-12-15 | Dinesh Shantilal Patel | Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel |
US6177477B1 (en) * | 1999-03-24 | 2001-01-23 | American Home Products Corporation | Propofol formulation containing TRIS |
US6635456B2 (en) * | 2001-02-09 | 2003-10-21 | Fidia Farmaceutici S.P.A. | Procedure for the preparation of pure phosphatides with phospholipase D |
US6803046B2 (en) * | 2002-08-16 | 2004-10-12 | Bracco International B.V. | Sincalide formulations |
KR100482269B1 (ko) * | 2002-10-08 | 2005-04-14 | 센츄론(주) | 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법 |
LT1585548T (lt) | 2002-12-09 | 2018-09-25 | Abraxis Bioscience, Llc | Farmakologinių agentų kompozicijos ir įvedimo būdai |
US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
US8476010B2 (en) | 2003-07-10 | 2013-07-02 | App Pharmaceuticals Llc | Propofol formulations with non-reactive container closures |
US8546453B2 (en) * | 2003-08-14 | 2013-10-01 | Rensheng Zhang | Propofol compositions and methods for reducing pain associated with propofol injection |
JP2005154305A (ja) * | 2003-11-21 | 2005-06-16 | Showa Yakuhin Kako Kk | ヒアルロン酸含有組成物の製造方法 |
CN100358513C (zh) * | 2005-04-07 | 2008-01-02 | 常州市第四制药厂有限公司 | 一种丙泊酚注射液的制备工艺 |
TWI429452B (zh) | 2005-08-31 | 2014-03-11 | Abraxis Bioscience Llc | 包含弱水溶性藥劑及抗微生物劑之組合物 |
EP1928435B8 (en) | 2005-08-31 | 2019-03-20 | Abraxis BioScience, LLC | Compositions of poorly water soluble drugs with increased stability and methods for preparation thereof |
CA2734284C (en) * | 2008-11-20 | 2014-01-21 | Techno Guard Co., Ltd. | Pyrazolone derivative formulations |
US11110063B2 (en) | 2017-08-25 | 2021-09-07 | MAIA Pharmaceuticals, Inc. | Storage stable sincalide formulations |
EP3761961A4 (en) * | 2018-03-07 | 2022-01-05 | Andrew Xian Chen | AQUEOUS FORMULATIONS FOR INSOLUBLE DRUGS |
JP7135670B2 (ja) * | 2018-09-27 | 2022-09-13 | 住友電気工業株式会社 | 光ファイバ及び紫外線硬化型樹脂組成物 |
JP7063217B2 (ja) * | 2018-09-27 | 2022-05-09 | 住友電気工業株式会社 | 光ファイバの製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1089510B (de) | 1959-03-23 | 1960-09-22 | Rudolf Reiss Dr | Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid |
GB1472793A (en) | 1974-03-28 | 1977-05-04 | Ici Ltd | Pharmaceutical compositions |
US4798846A (en) * | 1974-03-28 | 1989-01-17 | Imperial Chemical Industries Plc | Pharmaceutical compositions |
DE3221579A1 (de) | 1982-06-08 | 1983-12-22 | Eckert, Theodor, Prof. Dr., 4400 Münster | Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen |
CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
US5085864A (en) * | 1989-10-30 | 1992-02-04 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
DE4039602A1 (de) * | 1990-12-12 | 1992-06-17 | Bauer Kurt Heinz Prof Dr | Pharmazeutische formulierungen |
GB9405593D0 (en) * | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
ZA962214B (en) | 1995-04-10 | 1996-10-07 | Farmarc Nederland Bv | Pharmaceutical composition |
WO1997010814A1 (en) | 1995-09-18 | 1997-03-27 | Vesifact Ag | Propofol nanodispersions |
US5637625A (en) * | 1996-03-19 | 1997-06-10 | Research Triangle Pharmaceuticals Ltd. | Propofol microdroplet formulations |
-
1997
- 1997-05-26 CH CH01224/97A patent/CH692322A5/it not_active IP Right Cessation
-
1998
- 1998-05-14 KR KR1019997010985A patent/KR20010013011A/ko not_active Application Discontinuation
- 1998-05-14 BR BR9809492-0A patent/BR9809492A/pt not_active IP Right Cessation
- 1998-05-14 DE DE69810771T patent/DE69810771D1/de not_active Expired - Lifetime
- 1998-05-14 PL PL98337026A patent/PL337026A1/xx unknown
- 1998-05-14 AU AU82097/98A patent/AU735020B2/en not_active Ceased
- 1998-05-14 JP JP50019999A patent/JP2001527577A/ja active Pending
- 1998-05-14 TR TR2000/00116T patent/TR200000116T2/xx unknown
- 1998-05-14 HU HU0002117A patent/HUP0002117A3/hu unknown
- 1998-05-14 WO PCT/EP1998/003004 patent/WO1998053805A1/en not_active Application Discontinuation
- 1998-05-14 EP EP98932068A patent/EP0991405B1/en not_active Expired - Lifetime
- 1998-05-14 US US09/424,691 patent/US6326406B1/en not_active Expired - Fee Related
- 1998-05-14 AT AT98932068T patent/ATE230984T1/de not_active IP Right Cessation
- 1998-05-14 CA CA002291261A patent/CA2291261A1/en not_active Abandoned
- 1998-05-14 CN CN98806674A patent/CN1268051A/zh active Pending
- 1998-05-19 PE PE1998000393A patent/PE75299A1/es not_active Application Discontinuation
- 1998-05-21 IN IN917CA1998 patent/IN187550B/en unknown
- 1998-05-21 ZA ZA984314A patent/ZA984314B/xx unknown
- 1998-05-21 PA PA19988451701A patent/PA8451701A1/es unknown
- 1998-05-22 AR ARP980102379A patent/AR012853A1/es not_active Application Discontinuation
- 1998-05-25 DZ DZ980113A patent/DZ2503A1/xx active
- 1998-05-26 MY MYPI98002351A patent/MY132911A/en unknown
-
1999
- 1999-11-26 NO NO995831A patent/NO995831L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69810771D1 (de) | 2003-02-20 |
AR012853A1 (es) | 2000-11-22 |
PE75299A1 (es) | 1999-08-26 |
CN1268051A (zh) | 2000-09-27 |
JP2001527577A (ja) | 2001-12-25 |
HUP0002117A3 (en) | 2001-04-28 |
WO1998053805A1 (en) | 1998-12-03 |
PL337026A1 (en) | 2000-07-31 |
TR200000116T2 (tr) | 2000-05-22 |
NO995831D0 (no) | 1999-11-26 |
CA2291261A1 (en) | 1998-12-03 |
EP0991405B1 (en) | 2003-01-15 |
AU8209798A (en) | 1998-12-30 |
NO995831L (no) | 2000-01-26 |
MY132911A (en) | 2007-10-31 |
US6326406B1 (en) | 2001-12-04 |
AU735020B2 (en) | 2001-06-28 |
HUP0002117A2 (hu) | 2000-12-28 |
CH692322A5 (it) | 2002-05-15 |
PA8451701A1 (es) | 2000-05-24 |
EP0991405A1 (en) | 2000-04-12 |
ATE230984T1 (de) | 2003-02-15 |
DZ2503A1 (fr) | 2005-01-25 |
IN187550B (pt) | 2002-05-18 |
KR20010013011A (ko) | 2001-02-26 |
BR9809492A (pt) | 2000-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA984314B (en) | Clear injectable formulation of an anaesthetic compound | |
EP0785713A4 (en) | PRODUCTION OF AEROSOL FORMULATION OF INSULIN | |
HK1025904A1 (en) | Pharmaceutical composition for combination of piperidinoalkanol-decongestant | |
AU6883798A (en) | Method of anesthesia | |
AU1721697A (en) | Use of compositions comprising stabilized biologically effective compounds | |
ZA987800B (en) | Pharmaceutical composition of meloxicam | |
AU7389098A (en) | Local anesthetic formulations | |
EG24071A (en) | Injectable quinolone formulations | |
ZA985096B (en) | Composition compound and use | |
EP0976407A4 (en) | ANTISEPTIC COMPOSITIONS | |
EP0978288A4 (en) | DRUG COMPOSITION | |
HUP0004665A3 (en) | Anaesthetic formulation | |
GB9701674D0 (en) | Use of organic compounds | |
PL337804A1 (en) | Solubilised compositions of sertralin | |
ZA986465B (en) | Preparation of fluorinated compounds | |
SI1032390T1 (en) | Anaesthetic formulation | |
EG21166A (en) | Solubilization of boric acid | |
PL327430A1 (en) | Set of shaped components | |
TW364360U (en) | Improvement on structure of syringe | |
AUPO780497A0 (en) | Anaesthetic compositions | |
AUPO528897A0 (en) | Anaesthetic compositions | |
GB9818109D0 (en) | Anaesthetic Formulation | |
EP0981368A4 (en) | COLONIZATION FACTORS MASS SPECTROSCOPY | |
GB9722026D0 (en) | Use of compounds | |
GB9719092D0 (en) | Preparation of fluorinated organic compounds |